TL;DR
Turn quiet afternoons into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
PCOS has been officially renamed PMOS to better reflect its hormonal and metabolic causes. The change follows over a decade of advocacy and aims to improve diagnosis and treatment. The new name emphasizes the condition’s systemic effects beyond ovarian cysts.
Polycystic Ovary Syndrome (PCOS) has been officially renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) after more than a decade of advocacy, reflecting a shift in understanding from ovarian cysts to a broader hormonal and metabolic disorder.
This change was driven by input from over 14,000 patients and health professionals, and is supported by the World Health Organization. The new name corrects misconceptions that the condition is primarily ovarian cysts, highlighting its systemic effects on endocrine function, metabolism, cardiovascular health, and mental health. Experts like Dr. Tara Scott emphasize that the old name led to treatments focusing on ovarian cyst removal and hormonal suppression, which did not address the underlying metabolic issues. The renaming aims to improve diagnosis, which currently takes an average of five years and involves multiple doctors, with many women initially mistaking symptoms for PMS. The condition’s symptoms extend beyond reproductive concerns, increasing risks for obstetric complications, type 2 diabetes, cardiovascular disease, and mental health issues, especially depression linked to progesterone deficiency.
Why It Matters
The renaming of PCOS to PMOS is a significant step toward more accurate diagnosis and comprehensive treatment, potentially reducing the current diagnostic delay of over five years. Recognizing the condition as a systemic disorder could lead to better health outcomes, especially given its association with serious long-term risks like diabetes and heart disease. The change also highlights longstanding gaps in medical research and education about female-specific health issues, which have historically been underfunded and misunderstood.
PCOS metabolic health supplements
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Background
For decades, PCOS was misunderstood as primarily an ovarian issue, often leading to treatments focused on cyst removal or hormonal suppression with limited success. The condition affects an estimated 10% of women of reproductive age, yet the WHO estimates that 70% remain undiagnosed. The name change follows extensive advocacy, including input from patients and professionals, and aligns with a broader movement to recognize female health conditions as systemic and complex. This shift is part of ongoing efforts to improve awareness, diagnosis, and treatment of hormonal and metabolic disorders in women.
“The previous name suggested that the root cause was ovarian cysts, but it was actually a metabolic and endocrine disorder.”
— Dr. Tara Scott, MD
“An estimated 70% of people with this condition are currently undiagnosed.”
— WHO spokesperson
hormonal balance supplements for women
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
What Remains Unclear
It is still unclear how quickly the new terminology will influence clinical practice worldwide. The extent to which medical guidelines and insurance policies will adapt remains to be seen, and some practitioners may continue using the old term in the short term. Additionally, the impact of the name change on patient awareness and treatment outcomes has yet to be fully evaluated.
As an affiliate, we earn on qualifying purchases.
What’s Next
Medical organizations and health authorities are expected to update clinical guidelines to reflect the new terminology. Increased education efforts for healthcare providers and public awareness campaigns are likely to follow. Researchers may also focus more on systemic and metabolic aspects of the disorder, potentially leading to improved diagnostic tools and treatments.
metabolic support vitamins for women
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
Why was PCOS renamed to PMOS?
The name was changed to better reflect the condition’s hormonal and metabolic roots, moving away from the inaccurate focus on ovarian cysts.
Will this change affect current treatments?
While treatment approaches may evolve to address systemic issues more directly, existing treatments like hormonal therapies will still be used. The change aims to improve diagnosis and overall management.
How does the new name impact diagnosis and awareness?
The new name is intended to raise awareness of the systemic nature of the condition, potentially reducing diagnostic delays and encouraging more comprehensive care.
When will healthcare providers start using the new term?
Medical guidelines and official communications are expected to update in the coming months, but adoption may vary globally.
Does this mean women with ovarian cysts are now diagnosed differently?
Not necessarily; the change clarifies the underlying cause of many symptoms. Women with ovarian cysts remain diagnosed based on their specific clinical presentation, but the understanding of the condition’s systemic nature is now clearer.
Source: Motherly · Wellness
Fall Picks
fall essentials
As an affiliate, we earn on qualifying purchases.
